Immunocore
Bridgin Lee has extensive experience in portfolio strategy, program development, and business analytics within the biopharmaceutical industry. Currently serving as Senior Director at Immunocore, Bridgin has advanced from previous roles at Bristol Myers Squibb as Associate Director and Global Regulatory Lead in Oncology. Prior experience includes consulting at Booz Allen Hamilton, where Bridgin led strategic initiatives for drug evaluation and regulatory processes. Bridgin holds a Ph.D. in Pharmacology from the University of Pennsylvania, where involvement included serving as a member of the Institutional Review Board and co-president of the PBG Healthcare Consulting Group, managing healthcare consulting projects for various organizations. Educational background also includes a B.A. in Biology from St. Mary's College of Maryland.
This person is not in any teams
This person is not in any offices
Immunocore
1 followers
Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.